Clinical trial • Phase I • Oncology
Clinical trial in Advanced solid tumors
Phase I trial for Advanced solid tumors. 46 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Advanced solid tumors
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 26-01-2026
- First CTIS Authorization Date
- 08-05-2026
Trial design
Phase I trial across 3 sites in France, Spain.
- Target Sample Size
- 46
- Trial Duration For Participant
- 1657
Eligibility
Recruits 46 Vulnerable population selected; no details on consent or assent handling provided..
- Vulnerable Population
- Vulnerable population selected; no details on consent or assent handling provided.
Recruitment
- Planned Sample Size
- 46
- Recruitment Window Months
- 54
Geography
- Total Number Of Sites
- 3
- Total Number Of Participants
- 24
France
- Earliest CTIS Part Ii Submission Date
- 09-04-2026
- Latest Decision Or Authorization Date
- 11-05-2026
- Processing Time Days
- 32
- Number Of Sites
- 2
- Number Of Participants
- 12
Sites
- Site Name
- Centre Leon Berard
- Department Name
- Medical Oncology
- Contact Person Name
- Philippe CASSIER
- Contact Person Email
- philippe.cassier@lyon.unicancer.fr
- Site Name
- Oncopole Claudius Regaud
- Department Name
- Oncologie médicale
- Contact Person Name
- Carlos GOMEZ-ROCA
- Contact Person Email
- gomez-roca.carlos@iuct-oncopole.fr
Spain
- Earliest CTIS Part Ii Submission Date
- 21-04-2026
- Latest Decision Or Authorization Date
- 08-05-2026
- Processing Time Days
- 17
- Number Of Sites
- 1
- Number Of Participants
- 12
Sites
- Site Name
- Hospital Universitari Vall D Hebron
- Department Name
- Medical Oncology
- Contact Person Name
- Elena Garralda Cabanas
- Contact Person Email
- egarralda@vhio.net
Sponsor
Primary sponsor
- Full Name
- Daiichi Sankyo Inc.
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- United States
Related trials
Other published trials that may interest you.